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Summary: Pycnodysostosis is a rare sclerosing bone dystrophy. The
main clinical features are short stature and oral and maxillofacial
abnormalities such as a large head, a small and underdeveloped
face with prominent nose and eyes, irregular dentition, small hands
and feet with dystrophic nails, and trunk deformities such as scoliosis.
The diﬀerential diagnosis is established with other skeletal dysplasias
such as osteopetrosis, cleidocranial dysplasia, and idiopathic acro-
osteolysis. Since its ﬁrst description in 1962 by Maroteaux and Lamy,
about 100 cases have been published, some of these with uncommon
features. We describe the case of a 22-year-old European man with
pycnodysostosis who developed a chondroblastic osteosarcoma of
the right femur. No case of bone cancer in this sclerosing bone disease
had been described so far.
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Pycnodysostosis meaning “thick defective bones” (fromthe Greek pycnos=dense, dys=defective, and stosis
=of bone) is a rare sclerosing bone dystrophy. It was ﬁrst
described in 1962 by Maroteaux and Lamy as a variant of
osteopetrosis (Albers-Scho¨nberg disease).1 It is an autoso-
mal recessive disorder, the main clinical features of which
are short stature at all ages, large head with frontal and
parietal bossing, delayed closure of the fontanelles with wide,
unossiﬁed cranial sutures, a small and underdeveloped face,
with a beaked nose, prominent eyes, obtuse mandibular
angle, a high grooved palate, and irregular dentition. Hands
and feet are short, broad, with short terminal phalanges and
dystrophic lenticulate nails. The acromial end of the clavicles
is hypoplastic,s and trunk deformities such as scoliosis,
increased lumbar lordosis, or kyphosis can be seen.2–4
Usually diagnosed at an early age, the diagnosis is
sometimes late, made because of bone fracture due to severe
bone fragility resulting from increased bone density.5 The
diﬀerential diagnosis is to be made with other skeletal
dysplasias such as osteopetrosis, cleidocranial dysplasia,
and idiopathic acro-osteolysis.
No case of bone cancer in this sclerosing bone disease
has been described so far. We report the ﬁrst case of
chondroblastic osteosarcoma (OS) in a patient with
pycnodysostosis.
CASE REPORT
We present the case of a young man diagnosed with pycno-
dysostosis during his ﬁrst year of life. Born to consanguineous
parents and adopted at the age of 3 months, he showed the main
clinical features as presented before, such as short stature, a large
head with a small and underdeveloped face, and small hands and
feet with dystrophic nails (Fig. 1). He also had a cleft palate
(usually not described in pycnodysostosis). Diagnosis was based on
radiographs that showed typical signs of pycnodysostosis (Fig. 2).
This young man was referred to our department with a
7-month history of pain in his upper right leg. One month before
diagnosis he started to limp and a swelling appeared. X-ray showed
a large heavily calciﬁed mass on the upper part of his right femur;
magnetic resonance imaging scan showed a large tumor on the
right diaphysis of the femur (Fig. 3). Biopsy of the lesion conﬁrmed
the diagnosis of chondroblastic OS (Fig. 4). No metastasis was
found.
He was treated according to the French protocol osteo-
sarcoma 2006. Surgery consists of resection-reconstruction of the
bone. He has been in ﬁrst complete remission since >2 years after
the end of treatment.
DISCUSSION
Pycnodysostosis, an inherited autosomal recessive
disorder, is due to a genetic defect located on chromosome
1q21. Diﬀerent mutations6,7 located on this chromosome
are responsible for changes in a lysosomal cysteine pro-
tease, cathepsin K. This protease, expressed in osteoclasts,
is a key enzyme in the degradation of bone matrix proteins.
Because of the reduced expression of cathepsin K in the
osteoclasts, these cells are not able to remove the organic
matrix (95% of which is collagen type 1). This osteoclastic
dysfunction results in reduced bone resorption. Bone
resorption in pycnodysostosis is defective but not com-
pletely inhibited, as there is a nonosteoclastic pathway for
degradation of bone matrix.
Other bone-lining cells containing matrix metal-
loproteinase activities are able to degrade demineralized
collagen left over from osteoclasts.8,9 However, the collagen
breakdown products resulting from cathepsin K activity are
diﬀerent from those resulting from the alternative protei-
nases, which suggests that the microenvironment of bone is
altered.10 Furthermore, osteoblastic function and bone
formation seem to be altered as bone formation and bone
resorption are closely linked and the dysfunction of one can
imbalance the other. The abnormal bone turnover due to
cathepsin K deﬁciency in patients with pycnodysostosis
results in osteosclerosis and a highly disturbed bone
architecture that cannot adapt to mechanical stress. This
leads to a highly disordered lamellar structure and therefore
an increased susceptibility to fractures.11 Fractures are
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FIGURE 1. Our patient aged 22 years, his hand with short fingers.
FIGURE 2. A and B, Radiograph of the skull: enlarged sutures and presence of wormian bones at the lambdoid suture, no mandibular
angle. C, Radiograph of the rib cage: large and densified ribs, the distal end of the right clavicle is partly missing with congenital
pseudarthrosis. D, Radiograph of the hands: increased density with resorption of the terminal phalanges in fingers 1 to 3.
FIGURE 3. A, Radiograph of the right femur: increased density of the bone and a large calcified mass. B, Magnetic resonance imaging of
the right femur: large tumor (259.38.2 cm).
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frequent in this disease with an abnormal bone turnover,
but no case of malignant lesion has been described so far.
OS is a malignant mesenchymal sarcoma characterized
by the direct formation of bone or osteoid by tumors cells.
OS is subclassiﬁed on the basis of the histologic charac-
teristics of the cells: when the product of chondroid matrix
is predominant, the tumor is classiﬁed as a chondroblastic
OS.12 The metaphyses of long tubular bones are mostly
involved: distal femur (50%), proximal tibia (25%), prox-
imal humerus (10%), and proximal ﬁbula (5%).12,13
The etiology of OS remains unknown. Rapid bone
growth seems to predispose individuals to OS as suggested
by the increased incidence during adolescent growth spurt
and the typical location of this cancer in the metaphyseal
area. The only known environmental factor is radiation.
Bone dysplasias, including Paget disease, ﬁbrous dysplasias,
enchondromatosis, and hereditary multiple exostoses, are
risk factors. Some genetic predispositions have been iden-
tiﬁed, such as the constitutional mutation of the retino-
blastoma gene (germline Rb), the Li Fraumeni syndrome
(germline p53 mutation), and the autosomic recessive
Rothmund-Thomson syndrome (association of congenital
bone defects, hair and skin dysplasias, hypogonadism, and
cataracts).13 No clinical association with pycnodysostosis
has been described before.
CONCLUSIONS
We describe the ﬁrst case of chondroblastic OS in a
young man suﬀering from pycnodysostosis.
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FIGURE 4. Pathology of the tumor (HES 50): the tumor is
cellular, mainly composed of an immature chondroblastic com-
ponent, focally necrotic, and calcified with minimal osteoblastic
areas.
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